探测非肽激动剂与人类痛觉肽/孤啡肽FQ受体的结合:分子模型研究。

IF 3.597 Q2 Pharmacology, Toxicology and Pharmaceutics MedChemComm Pub Date : 2024-12-10 DOI:10.1039/D4MD00747F
Matteo Gozzi, Davide Malfacini, Valentina Albanese, Salvatore Pacifico, Delia Preti, Remo Guerrini, Girolamo Calò and Antonella Ciancetta
{"title":"探测非肽激动剂与人类痛觉肽/孤啡肽FQ受体的结合:分子模型研究。","authors":"Matteo Gozzi, Davide Malfacini, Valentina Albanese, Salvatore Pacifico, Delia Preti, Remo Guerrini, Girolamo Calò and Antonella Ciancetta","doi":"10.1039/D4MD00747F","DOIUrl":null,"url":null,"abstract":"<p >The N/OFQ–NOP receptor is a fascinating peptidergic system with the potential to be exploited for the development of analgesic drugs devoid of side effects associated with classical opioid signalling modulation. To date, up to four X-ray and cryo-EM structures of the NOP receptor in complex with the endogenous peptide agonist N/OFQ and three small molecule antagonists have been solved and released. Despite the available structural information, the details of selective small molecule agonist binding to the NOP receptor in the active state remain elusive. In this study, by leveraging the available structural information and using N/OFQ(1–13)-NH<small><sub>2</sub></small> as a reference compound, we developed a computational protocol based on docking followed by short molecular dynamics (MD) simulations that can suggest small molecule agonist binding modes at the NOP receptor that are reproducible and stable over time in the solvated membrane-embedded receptor active state and in agreement with known structure–activity relationship (SAR) data.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 4","pages":" 1584-1599"},"PeriodicalIF":3.5970,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study†\",\"authors\":\"Matteo Gozzi, Davide Malfacini, Valentina Albanese, Salvatore Pacifico, Delia Preti, Remo Guerrini, Girolamo Calò and Antonella Ciancetta\",\"doi\":\"10.1039/D4MD00747F\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The N/OFQ–NOP receptor is a fascinating peptidergic system with the potential to be exploited for the development of analgesic drugs devoid of side effects associated with classical opioid signalling modulation. To date, up to four X-ray and cryo-EM structures of the NOP receptor in complex with the endogenous peptide agonist N/OFQ and three small molecule antagonists have been solved and released. Despite the available structural information, the details of selective small molecule agonist binding to the NOP receptor in the active state remain elusive. In this study, by leveraging the available structural information and using N/OFQ(1–13)-NH<small><sub>2</sub></small> as a reference compound, we developed a computational protocol based on docking followed by short molecular dynamics (MD) simulations that can suggest small molecule agonist binding modes at the NOP receptor that are reproducible and stable over time in the solvated membrane-embedded receptor active state and in agreement with known structure–activity relationship (SAR) data.</p>\",\"PeriodicalId\":88,\"journal\":{\"name\":\"MedChemComm\",\"volume\":\" 4\",\"pages\":\" 1584-1599\"},\"PeriodicalIF\":3.5970,\"publicationDate\":\"2024-12-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedChemComm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/md/d4md00747f\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/md/d4md00747f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

N/OFQ-NOP受体是一个令人着迷的肽能系统,有潜力用于开发无副作用的镇痛药物,与经典的阿片信号调节相关。迄今为止,NOP受体与内源性肽激动剂N/OFQ和三种小分子拮抗剂复合物的x射线和低温电镜结构已被破解和释放。尽管有可用的结构信息,但选择性小分子激动剂在活性状态下与NOP受体结合的细节仍然难以捉摸。在这项研究中,利用现有的结构信息,并以N/OFQ(1-13)-NH2作为参考化合物,我们开发了一种基于对接和短分子动力学(MD)模拟的计算方案,该方案可以建议小分子激动剂在NOP受体上的结合模式,该模式在溶剂化膜嵌入受体活性状态下可重复且稳定,并且与已知的结构-活性关系(SAR)数据一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study†

The N/OFQ–NOP receptor is a fascinating peptidergic system with the potential to be exploited for the development of analgesic drugs devoid of side effects associated with classical opioid signalling modulation. To date, up to four X-ray and cryo-EM structures of the NOP receptor in complex with the endogenous peptide agonist N/OFQ and three small molecule antagonists have been solved and released. Despite the available structural information, the details of selective small molecule agonist binding to the NOP receptor in the active state remain elusive. In this study, by leveraging the available structural information and using N/OFQ(1–13)-NH2 as a reference compound, we developed a computational protocol based on docking followed by short molecular dynamics (MD) simulations that can suggest small molecule agonist binding modes at the NOP receptor that are reproducible and stable over time in the solvated membrane-embedded receptor active state and in agreement with known structure–activity relationship (SAR) data.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MedChemComm
MedChemComm BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
4.70
自引率
0.00%
发文量
0
审稿时长
2.2 months
期刊介绍: Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry. In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.
期刊最新文献
The effects of bioisostere substitution on the antimicrobial and physicochemical properties of supramolecular self-associating amphiphiles Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity Design, synthesis, and biological evaluation of X19: a matrine pyrazole derivatives therapeutic candidate Extending the architecture of bolaamphiphilic disinfectants: an investigation of octenidine and isooctenidine analogs The dual functions of a nor-sesquiterpene-triazole derivative against influenza A viruses through the activation of the Nrf2/HO-1 signaling pathway and interaction with hemagglutinin
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1